integrating insulin biosimilars into clinical practice: new pathways and new challenges
Published 4 years ago • 726 plays • Length 1:02:17Download video MP4
Download video MP3
Similar videos
-
51:06
biosimilars and oncology clinical pathways: perfect together
-
45:20
biosimilar integration in the patient-centered medical home
-
16:22
incorporating ibd biosimilars into practice: patient care and education
-
14:19
regulatory pathway for biosimilars
-
2:04
biosimilars: the path to approval
-
7:46
practical considerations in integrating her2 biosimilars in clinical practice
-
11:18
biosimilar and interchangeable insulins: what clinicians need to know
-
6:18
fda approves of biosimilar to infliximab – ibd in the news
-
2:45
understand #biosimilar interchangeability!
-
55:23
lunch & learn, november 18 – on the path toward #insulin4all: access, affordability & biosimilars
-
4:12
the basics of biosimilars
-
4:05
the biosimilar regulatory pathway
-
4:18
what is a biosimilar? biosimilars explained by a doctor and pharmacist
-
3:35:15
pharmacodynamic biomarkers for biosimilar development and approval: day 1
-
11:40
debate: biosimilar therapies - caution, more studies are needed
-
3:45
what are biosimilars? how do they work for arthritis?
-
1:38:19
accelerating regulatory pathway for biologics & biosimilar drugs
-
48:36
biosimilar workshop | mr. shreehas tambe
-
53:18
utilization of biosimilars: achieving value-based plan management